Integrated Genomic Analysis Identifies ANKRD36 Gene as a Novel and Common Biomarker of Disease Progression in Chronic Myeloid Leukemia. Here, ANKRD36 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.